← Eichor
Condition: Alzheimer Dementia Ad Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Alzheimer Dementia Ad

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0
NA · 1 location(s) · Hebrew SeniorLife · NCT05950607Evaluation of a Neuropsychological Tool to Assess Temporal Processing Abilities in Alzheimer's Disease
Phase N/A · 1 location(s) · University Hospital, Caen · NCT07341009Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases （ACT-AD）
NA · 4 location(s) · Xijing Hospital · NCT06669182A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease P
Phase 2 · 2 location(s) · Elixiron Immunotherapeutics Inc. · NCT06745583Deep Cervical Lymphatic Venous Anastomosis in the Treatment of Alzheimer's Disease (CLEAN-AD)
NA · 9 location(s) · Beijing Tiantan Hospital · NCT07073066Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)
Phase 1/Phase 2 · 1 location(s) · University of California, Los Angeles · NCT06597942Social-cognitive Functioning: Validation of a New Neuropsychological Test
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05558709Open-Label Extension Protocol to SNK01-AD01 Study
Phase 2 · 1 location(s) · NKGen Biotech, Inc. · NCT07228078Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistic
NA · 1 location(s) · HudsonAlpha Institute for Biotechnology · NCT07146412Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis
Phase N/A · 1 location(s) · Capital Medical University · NCT04850053Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT04124029Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
EARLY_Phase 1 · 2 location(s) · University of Pennsylvania · NCT06932809Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging
NA · 1 location(s) · Natalie Denburg · NCT03954899A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Phase 3 · 143 location(s) · Hoffmann-La Roche · NCT07169578δ in Dementia Clinical Trials
NA · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT05592678Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain F
NA · 1 location(s) · Boston University Charles River Campus · NCT07659964A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK
Phase 1 · 2 location(s) · University College, London · NCT06372821A Study of AMDX-2011P in Participants With Alzheimer's Disease
Phase 2 · 1 location(s) · Amydis Inc. · NCT06514001A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
NA · 1 location(s) · Arizona State University · NCT05877196Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's
Phase 2 · 1 location(s) · Bernard (Barry) Baumel · NCT07512362Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease
Phase N/A · 1 location(s) · Peking University First Hospital · NCT06924359Novel Personalized Non Invasive Combined Magnetic and Electrical Stimulation of the DMN in Mild AD Patients
NA · 2 location(s) · I.R.C.C.S. Fondazione Santa Lucia · NCT07075770Speech Pattern Evaluation and Analysis for Knowledge of AD
Phase N/A · 1 location(s) · University of Wisconsin, Madison · NCT06230783A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by
Phase 2/Phase 3 · 37 location(s) · Washington University School of Medicine · NCT05552157Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study
Phase 1 · 1 location(s) · National University Hospital, Singapore · NCT07210528Multimodal Assesment of Alzheimer Patients
Phase N/A · 1 location(s) · Norwegian University of Science and Technology · NCT06448403The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Diseas
NA · 8 location(s) · Alzheimercentrum Amsterdam · NCT07680335The Co-Production and Evaluation of the Computerised Cognitive Assessment for Preclinical Alzheimer's Disease (CoCoA-PAD
Phase N/A · 3 location(s) · University of Plymouth · NCT07598617Brain Energy for Amyloid Transformation in Alzheimer's Disease Study
NA · 1 location(s) · Wake Forest University Health Sciences · NCT03472664Cerebrospinal Fluid Mitochondrial Biomarkers in Ischemic Stroke and Alzheimer Disease
Phase N/A · 1 location(s) · Capital Medical University · NCT07600996
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.